Cargando…
Cellular and molecular defects in a patient with Hermansky-Pudlak syndrome type 5
Hermansky-Pudlak syndrome (HPS) is a heterogeneous group of genetic disorders typically manifesting with tyrosinase-positive oculocutaneous albinism, bleeding diathesis, and pulmonary fibrosis, in some subtypes. Most HPS subtypes are associated with defects in Biogenesis of Lysosome-related Organell...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351877/ https://www.ncbi.nlm.nih.gov/pubmed/28296950 http://dx.doi.org/10.1371/journal.pone.0173682 |
_version_ | 1782514843261075456 |
---|---|
author | Stephen, Joshi Yokoyama, Tadafumi Tolman, Nathanial J. O’Brien, Kevin J. Nicoli, Elena-Raluca Brooks, Brian P. Huryn, Laryssa Titus, Steven A. Adams, David R. Chen, Dong Gahl, William A. Gochuico, Bernadette R. Malicdan, May Christine V. |
author_facet | Stephen, Joshi Yokoyama, Tadafumi Tolman, Nathanial J. O’Brien, Kevin J. Nicoli, Elena-Raluca Brooks, Brian P. Huryn, Laryssa Titus, Steven A. Adams, David R. Chen, Dong Gahl, William A. Gochuico, Bernadette R. Malicdan, May Christine V. |
author_sort | Stephen, Joshi |
collection | PubMed |
description | Hermansky-Pudlak syndrome (HPS) is a heterogeneous group of genetic disorders typically manifesting with tyrosinase-positive oculocutaneous albinism, bleeding diathesis, and pulmonary fibrosis, in some subtypes. Most HPS subtypes are associated with defects in Biogenesis of Lysosome-related Organelle Complexes (BLOCs), which are groups of proteins that function together in the formation and/or trafficking of lysosomal-related endosomal compartments. BLOC-2, for example, consists of the proteins HPS3, HPS5, and HPS6. Here we present an HPS patient with defective BLOC-2 due to a novel intronic mutation in HPS5 that activates a cryptic acceptor splice site. This mutation leads to the insertion of nine nucleotides in-frame and results in a reduced amount of HPS5 at the transcript and protein level. In studies using skin fibroblasts derived from the proband and two other individuals with HPS-5, we found a perinuclear distribution of acidified organelles in patient cells compared to controls. Our results suggest the role of HPS5 in the endo-lysosomal dynamics of skin fibroblasts. |
format | Online Article Text |
id | pubmed-5351877 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-53518772017-04-06 Cellular and molecular defects in a patient with Hermansky-Pudlak syndrome type 5 Stephen, Joshi Yokoyama, Tadafumi Tolman, Nathanial J. O’Brien, Kevin J. Nicoli, Elena-Raluca Brooks, Brian P. Huryn, Laryssa Titus, Steven A. Adams, David R. Chen, Dong Gahl, William A. Gochuico, Bernadette R. Malicdan, May Christine V. PLoS One Research Article Hermansky-Pudlak syndrome (HPS) is a heterogeneous group of genetic disorders typically manifesting with tyrosinase-positive oculocutaneous albinism, bleeding diathesis, and pulmonary fibrosis, in some subtypes. Most HPS subtypes are associated with defects in Biogenesis of Lysosome-related Organelle Complexes (BLOCs), which are groups of proteins that function together in the formation and/or trafficking of lysosomal-related endosomal compartments. BLOC-2, for example, consists of the proteins HPS3, HPS5, and HPS6. Here we present an HPS patient with defective BLOC-2 due to a novel intronic mutation in HPS5 that activates a cryptic acceptor splice site. This mutation leads to the insertion of nine nucleotides in-frame and results in a reduced amount of HPS5 at the transcript and protein level. In studies using skin fibroblasts derived from the proband and two other individuals with HPS-5, we found a perinuclear distribution of acidified organelles in patient cells compared to controls. Our results suggest the role of HPS5 in the endo-lysosomal dynamics of skin fibroblasts. Public Library of Science 2017-03-15 /pmc/articles/PMC5351877/ /pubmed/28296950 http://dx.doi.org/10.1371/journal.pone.0173682 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication. |
spellingShingle | Research Article Stephen, Joshi Yokoyama, Tadafumi Tolman, Nathanial J. O’Brien, Kevin J. Nicoli, Elena-Raluca Brooks, Brian P. Huryn, Laryssa Titus, Steven A. Adams, David R. Chen, Dong Gahl, William A. Gochuico, Bernadette R. Malicdan, May Christine V. Cellular and molecular defects in a patient with Hermansky-Pudlak syndrome type 5 |
title | Cellular and molecular defects in a patient with Hermansky-Pudlak syndrome type 5 |
title_full | Cellular and molecular defects in a patient with Hermansky-Pudlak syndrome type 5 |
title_fullStr | Cellular and molecular defects in a patient with Hermansky-Pudlak syndrome type 5 |
title_full_unstemmed | Cellular and molecular defects in a patient with Hermansky-Pudlak syndrome type 5 |
title_short | Cellular and molecular defects in a patient with Hermansky-Pudlak syndrome type 5 |
title_sort | cellular and molecular defects in a patient with hermansky-pudlak syndrome type 5 |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351877/ https://www.ncbi.nlm.nih.gov/pubmed/28296950 http://dx.doi.org/10.1371/journal.pone.0173682 |
work_keys_str_mv | AT stephenjoshi cellularandmoleculardefectsinapatientwithhermanskypudlaksyndrometype5 AT yokoyamatadafumi cellularandmoleculardefectsinapatientwithhermanskypudlaksyndrometype5 AT tolmannathanialj cellularandmoleculardefectsinapatientwithhermanskypudlaksyndrometype5 AT obrienkevinj cellularandmoleculardefectsinapatientwithhermanskypudlaksyndrometype5 AT nicolielenaraluca cellularandmoleculardefectsinapatientwithhermanskypudlaksyndrometype5 AT brooksbrianp cellularandmoleculardefectsinapatientwithhermanskypudlaksyndrometype5 AT hurynlaryssa cellularandmoleculardefectsinapatientwithhermanskypudlaksyndrometype5 AT titusstevena cellularandmoleculardefectsinapatientwithhermanskypudlaksyndrometype5 AT adamsdavidr cellularandmoleculardefectsinapatientwithhermanskypudlaksyndrometype5 AT chendong cellularandmoleculardefectsinapatientwithhermanskypudlaksyndrometype5 AT gahlwilliama cellularandmoleculardefectsinapatientwithhermanskypudlaksyndrometype5 AT gochuicobernadetter cellularandmoleculardefectsinapatientwithhermanskypudlaksyndrometype5 AT malicdanmaychristinev cellularandmoleculardefectsinapatientwithhermanskypudlaksyndrometype5 |